insights_auto
Outlook: 56.2% bullish·15.6% bearish
Go to analysischevron_right
UTHR:NASDAQ
United Therapeutics Corp
$537.86
arrow_upward
+0.27%(+1.46) 1D
Oct 6, 1:28:27 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for UTHR...
Open
$537.19
High
$542.48
Low
$527.33
Mkt. cap
23.30B
Avg. vol.
822.24K
Volume
282.21K
P/E ratio
19.24
52-wk high
$609.35
52-wk low
$409.15
EPS
$27.96
Beta
0.49
Shares outstanding
42.89M
No. of employees
1K
Open
$537.19
High
$542.48
Low
$527.33
Mkt. cap
23.30B
Avg. vol.
822.24K
Volume
282.21K
P/E ratio
19.24
52-wk high
$609.35
52-wk low
$409.15
EPS
$27.96
Beta
0.49
Shares outstanding
42.89M
No. of employees
1K
News stories
From web sources and news partners
www.marketscreener.com
·
20 hours ago
United Therapeutics Insider Sold Shares Worth $5,219,015, According to a Recent SEC Filing
Traders Union
·
20 hours ago
Liquidia faces patent ruling risk after Yutrepia launch boosts revenue
Profile
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
About United Therapeutics Corp
CEO-
Employees1.4K
Founded1996
HeadquartersSilver Spring, Maryland, United States
SectorBiotechnology
Websiteunither.com